跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,561 条关于
“malignant mesothelioma”
全部
7,561
临床试验
6,785
药物
28
机构
4
资讯
744
去年
CHMP Recommends Pembrolizumab Plus Chemotherapy for Non-Epithelioid Malignant Pleural Mesothelioma
去年
Roswell Park Celebrates 20 Years of Precision Medicine in Mesothelioma Treatment
2年前
FDA Approves Keytruda for First-Line Treatment of Malignant Pleural Mesothelioma
去年
EMA Committee Recommends Keytruda Plus Chemotherapy for Non-Epithelioid Mesothelioma
去年
BNT327/PM8002 Bispecific Antibody Shows Promising Activity in Unresectable Mesothelioma
去年
European Agency Signals Approval for Keytruda as First-Line Mesothelioma Treatment
去年
GSK's Zejula Shows Promising Results in Phase II Mesothelioma Trial with 27% Reduction in Disease Progression
去年
FDA Grants Orphan Drug Designation to VT3989 for Mesothelioma Treatment
3个月前
Amivantamab Shows Preclinical Immune-Mediated Activity in Mesothelioma Through Dual EGFR/MET Targeting
去年
FDA Approves New Therapies from Lilly, Novartis, Merck, J&J, and AstraZeneca
第 1 页,共 75 页
上一页
下一页